NPHLA Daily
NPHLA Daily
Monday, November 16, 2026 · 3-minute read
Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.
Top development today
What changed today in Aesthetics & Longevity: 2 new studies
NPHLA tracked 2 new official records on this desk today: 2 new studies. First: New research in Lasers in medical science: “Exosome-based topical formulations as adjuncts to fractional Nd: YAG laser for postoperative facial scars”.
Aesthetics & Longevity signal
Exosome-based topical formulations as adjuncts to fractional Nd: YAG laser for postoperative facial scars
From Lasers in medical science.
One thing worth watching
Comments close: Compounding Animal Drugs From Bulk Drug Substances: Compounding Under CGMP in Federally-Registered Facilities; Draft Guidance for Industry; Availability; Agency Information…
November 26, 2026 — verified from the Federal Register comments_close_on.
5 things to know
- What changed today in Aesthetics & Longevity: 2 new studies
- Exosome-based topical formulations as adjuncts to fractional Nd: YAG laser for postoperative facial scars (Lasers in medical science)
- Intradermal Injection of Exocean Plant Derived Exosomes: Human Scalp Histological and Morphometric Changes (Plastic and reconstructive surgery. Global open)
Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.

